Novo Nordisk A/S: Fatty Liver trials

The registry lists 13 Fatty Liver studies with Novo Nordisk A/S as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 8Phase 2 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Multiple Dose Study for a New Medication to Potentially Treat Liver DiseasesRecruitingNCT06891365Phase 1
• A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT04767529Phase 2Results posted
• A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT03976401Phase 2Results posted
• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.CompletedNCT02970942Phase 2Results posted
• A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up DatabaseCompletedNCT06741111
• A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedNCT06188026Phase 1
• A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
• Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-surveyCompletedNCT05765890
• A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedNCT05742919Phase 1
• A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT05727644Phase 1
• First Human Dose Trial for a New Medication to Potentially Treat Liver DiseasesCompletedNCT05599945Phase 1
• A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenCompletedNCT04722653Phase 1
• A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1